Filing Flows › Selectis Health (GBCS) › Q2 2026
Selectis Health (GBCS) Q2 2026 earnings results (second quarter 2026)
10-Q filed Aug 24, 2026
Selectis Health (GBCS) reported revenue of $4.7M for the second quarter 2026 (Q2 2026), -55% from a year earlier and -35% from the quarter before. Operating margin was -44.5%, net earnings $8.1M (171.9% of revenue).
Selectis Health, Q2 2026: revenue $4.7M (-55% year over year), operating margin -44.5%, net earnings $8.1M, operating cash flow −$2.0M. The chart follows the revenue to costs, profit and cash.
| Q2 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $4.7M | -35% | -55% |
| Operating profit | −$2.1M | — | — |
| Net earnings | $8.1M | +24% | — |
| Operating cash flow | −$2.0M | — | — |
What changed
Revenue was $4.7M in Q2 2026, down 55% year over year and down 35% from the previous quarter. Health Care was the largest line at 98% of revenue. Health Care lost $5.8M year over year (down 56%), 102% of the total change.
Operating costs exceeded revenue by $2.1M, an operating margin of -44.5%. Total costs fell 37% while revenue fell 55%. Net earnings were $8.1M. The effective tax rate was 5.5%. Non-operating items added $10.7M, 124% of pre-tax earnings, so the bottom line overstates operating performance.
Operating cash flow was −$2.0M. Non-cash charges added back $229K of depreciation. Working capital and other items used $10.4M. Capital expenditures of $32K exceeded it, leaving free cash flow of −$2.1M.
Questions
What was Selectis Health's revenue in the second quarter 2026?
Selectis Health (GBCS) reported revenue of $4.7M for the second quarter 2026 (Q2 2026), -55% from a year earlier and -35% from the quarter before.
Was Selectis Health profitable in the second quarter 2026?
Operating loss was $2.1M (-44.5% of revenue) and net earnings $8.1M.
Source: Selectis Health 10-Q on SEC EDGAR.